Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2008 1
2009 2
2010 2
2011 4
2012 5
2013 5
2014 10
2015 8
2016 8
2017 15
2018 9
2019 8
2020 9
2021 15
2022 15
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Reply to M Yildiz et al.
Jensen MM, Færch K, Brock C, Quist JS. Jensen MM, et al. Among authors: faerch k. J Nutr. 2024 Apr 13:S0022-3166(24)00213-X. doi: 10.1016/j.tjnut.2024.04.013. Online ahead of print. J Nutr. 2024. PMID: 38615732 No abstract available.
Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial.
Quist JS, Pedersen HE, Jensen MM, Clemmensen KKB, Bjerre N, Ekblond TS, Uldal S, Størling J, Wewer Albrechtsen NJ, Holst JJ, Torekov SS, Nyeland ME, Vistisen D, Jørgensen ME, Panda S, Brock C, Finlayson G, Blond MB, Færch K. Quist JS, et al. Among authors: faerch k. Lancet Healthy Longev. 2024 Apr 5:S2666-7568(24)00028-X. doi: 10.1016/S2666-7568(24)00028-X. Online ahead of print. Lancet Healthy Longev. 2024. PMID: 38588687 Free article.
Predicting the HbA1c level following glucose-lowering interventions in individuals with HbA1c-defined prediabetes: a post-hoc analysis from the randomized controlled PRE-D trial.
Bruhn L, Vistisen D, Amadid H, Clemmensen KKB, Karstoft K, Ried-Larsen M, Persson F, Jørgensen ME, Møller CL, Stallknecht B, Færch K, Blond MB. Bruhn L, et al. Among authors: faerch k. Endocrine. 2023 Jul;81(1):67-76. doi: 10.1007/s12020-023-03384-w. Epub 2023 May 17. Endocrine. 2023. PMID: 37198379 Clinical Trial.
Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists.
Umapathysivam MM, Araldi E, Hastoy B, Dawed AY, Vatandaslar H, Sengupta S, Kaufmann A, Thomsen S, Hartmann B, Jonsson AE, Kabakci H, Thaman S, Grarup N, Have CT, Færch K, Gjesing AP, Nawaz S, Cheeseman J, Neville MJ, Pedersen O, Walker M, Jennison C, Hattersley AT, Hansen T, Karpe F, Holst JJ, Jones AG, Ristow M, McCarthy MI, Pearson ER, Stoffel M, Gloyn AL. Umapathysivam MM, et al. Among authors: faerch k. medRxiv [Preprint]. 2023 Apr 12:2023.04.07.23288197. doi: 10.1101/2023.04.07.23288197. medRxiv. 2023. PMID: 37090505 Free PMC article. Preprint.
116 results